ZoetisTM (NYSE: ZTS), formerly the animal health business of
Pfizer Inc., will host a webcast and conference call at 8:30 a.m. (EDT)
on Tuesday, April 30, 2013. Chief Executive Officer Juan Ramón Alaix and
Executive Vice President and Chief Financial Officer Rick Passov will
review first-quarter 2013 financial results, discuss 2013 financial
guidance, and respond to questions from financial analysts during the
call.
Investors and the public may access the live webcast by visiting the
Zoetis website at http://www.zoetis.com/events-and-presentations.
Information on accessing and pre-registering for the webcast is
available beginning today. A replay of the webcast will be archived and
made available on April 30.
About Zoetis
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on a 60-year
history as the animal health business of Pfizer, Zoetis discovers,
develops, manufactures and markets veterinary vaccines and medicines,
with a focus on both farm and companion animals. The company generated
annual revenues of $4.2 billion in 2011. It had approximately 9,500
employees and a local presence in approximately 70 countries, including
29 manufacturing facilities in 11 countries. Its products serve
veterinarians, livestock producers and people who raise and care for
farm and companion animals in 120 countries.
DISCLOSURE NOTICE: This
news release contains forward-looking statements, which reflect Zoetis’
current views with respect to business plans or prospects, future
operating or financial performance, and other future events. These
statements are not guarantees of future performance. Forward-looking
statements are subject to risks and uncertainties. If one or more of
these risks or uncertainties materialize, or if management's underlying
assumptions prove to be incorrect, actual results may differ materially
from those contemplated by a forward-looking statement. Forward-looking
statements speak only as of the date on which they are made. Zoetis
expressly disclaims any obligation to update or revise any
forward-looking statement, whether as a result of new information,
future events or otherwise. A further list and description of
these risks, uncertainties and other factors can be found in Zoetis’
Registration Statement on Form S-1 (File No. 333-183254), as amended,
filed with the Securities and Exchange Commission. This filing
and subsequent filings are available online at www.sec.gov
or on request from Zoetis.
Zoetis
Media:
Bill Price, 973-660-5763
william.price@zoetis.com
or
Elinore White, 973-401-4044
elinore.y.white@zoetis.com
or
Investor:
Dina Fede, 973-660-5441
or
John O'Connor, 973-660-6964